We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
12 hedge funds and large institutions have $775K invested in Atossa Therapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
14% less funds holding
Funds holding: 14 → 12 (-2)
33% less capital invested
Capital invested by funds: $1.15M → $775K (-$378K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$30.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$12.8K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$5.13K |
Top Sellers
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$59K |
| 2 |
FCCM
First City Capital Management
Savannah,
Georgia
|
-$20.3K |
| 3 |
Citigroup
New York
|
-$4K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.57K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.57K |
